Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
66.00
-0.70 (-1.05%)
Apr 17, 2026, 1:53 PM CST

Shine-On BioMedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,2873,4863,3913,4563,147-
Market Cap Growth
0.15%2.79%-1.87%9.81%--
Enterprise Value
2,3662,5312,3022,3022,250-
Last Close Price
66.0070.0068.1069.4063.20-
PS Ratio
109.56116.20-362.89--
PB Ratio
3.623.843.333.042.68-
P/TBV Ratio
3.663.883.353.052.69-
EV/Sales Ratio
78.8784.38-241.71--
Debt / Equity Ratio
0.000.000.0000.000.00
Net Debt / Equity Ratio
-1.01-1.01-1.02-1.00-0.99-1.00
Net Debt / EBITDA Ratio
7.467.467.6818.3464.4780.51
Net Debt / FCF Ratio
8.028.0211.3742.1852.6284.40
Asset Turnover
0.030.03-0.01--
Quick Ratio
21.2421.2425.7649.41368.83330.77
Current Ratio
21.4821.4825.9249.61369.30330.89
Return on Equity (ROE)
-11.46%-11.46%-11.04%-3.22%-1.88%-
Return on Assets (ROA)
-7.80%-7.80%-7.66%-3.35%-1.11%-
Return on Capital Employed (ROCE)
-13.80%-13.80%-13.40%-5.50%-1.60%-1.30%
Earnings Yield
-3.36%-3.16%-3.51%-1.07%-0.62%-
FCF Yield
-3.49%-3.29%-2.70%-0.78%-0.70%-
Buyback Yield / Dilution
-0.21%-0.21%--9.67%-145.83%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.